TIL News

The IPO market stayed busy this past week, with 11 IPOs raising $3.0 billion. The week’s IPOs were joined by 24 SPACs that raised $8.4 billion. New filers continued to fill the IPO pipeline, with 8 IPOs and 46 SPACs submitting initial filings. Chinese IoT platform developer Tuya (TUYA) priced above the range to raise $915 million at an $11.8 billion...read more

Instil Bio, an early stage biotech developing immune cell therapies for cancer, raised $320 million by offering 16 million shares at $20, the high end of the upwardly revised range of $19 to $20. The company had originally planned to offer 13.9 million shares at a range of $17 to $19 before increasing the terms on Thursday. Instil Bio is developing a cell therapy pipeline...read more

Instil Bio, an early stage biotech developing immune cell therapies for cancer, raised the proposed deal size for its upcoming IPO on Thursday. The Dallas, TX-based company now plans to raise $312 million by offering 16 million shares at a price range of $19 to $20. The company had previously filed to offer 13.9 million shares at a range of $17 to $19. At the midpoint of the...read more

Instil Bio, an early stage biotech developing cell therapies for cancer, announced terms for its IPO on Monday. The Dallas, TX-based company plans to raise $250 million by offering 13.9 million shares at a price range of $17 to $19. At the midpoint of the proposed range, Instil Bio would command a fully diluted market value of $2.5 billion. Instil Bio is developing a cell...read more